Lmr Partners LLP Immunity Bio, Inc. Transaction History
Lmr Partners LLP
- $10.5 Billion
- Q2 2025
A detailed history of Lmr Partners LLP transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Lmr Partners LLP holds 838,700 shares of IBRX stock, worth $2.05 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
838,700
Previous 183,200
357.81%
Holding current value
$2.05 Million
Previous $551,000
301.81%
% of portfolio
0.02%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding IBRX
# of Institutions
271Shares Held
120MCall Options Held
2.49MPut Options Held
3.14M-
Vanguard Group Inc Valley Forge, PA21.8MShares$53.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$28 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC8.76MShares$21.5 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY7.76MShares$19 Million0.36% of portfolio
-
Jane Street Group, LLC New York, NY7.72MShares$18.9 Million0.0% of portfolio
About ImmunityBio, Inc.
- Ticker IBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 400,304,000
- Market Cap $981M
- Description
- ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...